Objective: The aim of this paper is to examine the base for integrating biomedical, psychological and social strategies in the management of schizophrenia. Method: A review of the literature on schizophrenia with particular emphasis in management considerations.
Results: Effective treatment components include psychoeducation, medication strategies, carer-based stress management training, community-based intensive treatment, living skills training, and specific drug and cognitive-behavioural strategies for residual symptoms.
Conclusions: Treatment for schizophrenia is best provided by integrating the various and specific psychosocial intervention strategies in addition to the optimal use of medication. Methods for implementing these strategies in outpatient settings include the use of a comprehensive assessment and treatment plan, the training of mental health professionals, and periodic review with assessment packages.
ShepherdMWattDFalloonISmeetonN.The natural history of schizophrenia. Psychological Medicine Monograph #16. Cambridge: Cambridge University Press, 1989.
2.
FalloonIRHShanahanWJCommunity management of schizophrenia. British Journal of Hospital Medicine1990; 43:62–66.
3.
LamDHPsychosocial family intervention in schizophrenia: a review of empirical studies. Psychological Medicine1991; 21:423–441.
4.
Quality Assurance Project.Treatment outlines for the management of schizophrenia. Australian and New Zealand Journal of Psychiatry1984; 18:19–38.
5.
World Health Organization.Evaluation of methods for the treatment of mental disorders. Technical report series #812. Geneva: World Health Organization, 1991.
6.
KaneJMMcGlashanTHTreatment of schizophrenia. Lancet1995; 346:820–825.
7.
LehmanAFCarpenterWTGoldmanHHSteinwachsDMTreatment outcomes in schizophrenia: implications for practice, policy and research. Schizophrenia Bulletin1995; 21:669–675.
8.
American Psychiatric Association.Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry1997; 154(Suppl.):1–63.
9.
FalloonIRHFaddenG.Integrated mental health care. Cambridge: Cambridge University Press, 1993.
10.
McCulloughLBCoverdaleJBayerTChervenakFAEthically justified guidelines for family planning intervention to prevent pregnancy in female patients with chronic mental illness. American Journal of Obstetrics and Gynecology1992; 167:19–25.
11.
SolomonPDraineJMannionEMeiselM.Impact of brief family psychoeducation on self-efficacy. Schizophrenia Bulletin1996; 22:41–50.
12.
MacphersonRJerromBHughesA.A controlled study of education about drug treatment in schizophrenia. British Journal of Psychiatry1996; 168:709–717.
13.
SchoolerNRMaintenance medication for schizophrenia: strategies for dose reduction. Schizophrenia Bulletin1991; 17:311–324.
14.
FalloonIRHLibermanRPInteractions between drug and psychosocial therapy in schizophrenia. Schizophrenia Bulletin1983; 9:543–54.
15.
van PuttenTMarderSRWirschingWCAravagiriMChabertN.Neuroleptic plasma levels. Schizophrenia Bulletin1991; 17:197–216.
16.
McEvoyJPHogartyGESteingardS.Optimal dose of neuroleptic in acute schizophrenia. A controlled study of neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry1991; 48:739–745.
17.
MeltzerHYTreatment of the neuroleptic non-responsive schizophrenic patient. Schizophrenia Bulletin1992; 18:515–542.
18.
DixonLBLehmanAFLevineJ.Conventional antipsychotic medications for schizophrenia. Schizophrenia Bulletin1995; 21:567–577.
19.
MariJDJStreinerDLAn overview of family interventions and relapse of schizophrenia: meta-analysis of research findings. Psychological Medicine1994; 24:565–578.
20.
FalloonIRHGraham-HoleVFaddenGIntegrated mental health care: a programme of training in clinical management of mental disorders using effective, efficient intervention strategies within a multidisciplinary team. Auckland: The University of Auckland, 1996.
21.
GruzelierJThorntonSStaniforthDZakiSYorkstonN.Active and passive avoidance learning in controls and schizophrenic patients on racemic propanolol and neuroleptics. British Journal of Psychiatry1980; 137:131–137.
22.
FalloonIRHFamily management of schizophrenia. Baltimore, MD: Johns Hopkins University Press, 1985.
23.
DoaneJAGoldsteinMJMiklowitzDJFalloonIRHThe impact of individual and family treatment on the affective climate of families of schizophrenics. British Journal of Psychiatry1986; 148:279–287.
24.
DoaneJAFalloonIRHAssessing change in family interactions: methodology and findings. In: FalloonIRH, ed. Family management of schizophrenia. Baltimore, MD; John Hopkins University Press, 1985:153–170.
25.
FalloonIRHCoverdaleJHBrookerC.Psychosocial interventions in schizophrenia: a review. International Journal of Mental Health1996; 25:3–21.
26.
ScottJEDixonLBAssertive community treatment and case management for schizophrenia. Schizophrenia Bulletin1995; 21:657–668.
27.
EngelhardtHTCoverdaleJHThe psychiatric admission index: deciding when to admit a patient. Journal of Clinical Ethics1993; 4:315–318.
28.
CoverdaleJHFalloonIRHHome or hospital-based emergency care for chronic psychiatric patients?New Zealand Medical Journal1993; 106:218–219.
29.
LehmanAFStrategies for improving services for the chronic mentally ill. Hospital and Community Psychiatry1989; 40:916–920.
30.
PennDLMueserKTResearch update on the psychosocial treatment of schizophrenia. American Journal of Psychiatry1996; 153:607–617.
31.
WallaceCJLibermanRPSocial skills training for patients with schizophrenia: a controlled clinical trial. Psychiatry Research1985; 15:239–247.
32.
HogartyGEAndersonCMReissDJFamily psycho-education, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Archives of General Psychiatry1991; 48:340–347.
33.
LehmanAFCarpenterWTGoldmanHHSteinwachsDMTreatment outcomes in schizophrenia: implications for practice, policy and research. Schizophrenia Bulletin1995; 21:669–675.
34.
BuchananRWClozapine: efficacy and safety. Schizophrenia Bulletin1995; 21:579–591.
35.
TarrierNBeckettRHarwoodSBakerAYusupoffLUgarteburuI.A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry1993; 162:524–532.
36.
KaneJMMarderSRPsychopharmacologic treatment of schizophrenia. Schizophrenia Bulletin1993; 19:287–302.
37.
LibermanRPModules for training social and independent living skills. California: Psychiatric Rehabilitation Consultants, Camarillo/UCLA Research Center, 1986–1989.
38.
McGorryPDEdwardsJ.Early psychosis training pack. Macclesfield, UK: Gardiner-Caldwell Communications, 1997.
39.
DickeyBAzeniH.Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatic care. American Journal of Public Health1996; 86:973–977.
40.
CardinVAMcGillCWFalloonIRHAn economic analysis: costs, benefits and effectiveness. In: FalloonIRH, ed. Family management of schizophrenia. Baltimore, MD; Johns Hopkins University Press, 1985:115–123.
41.
TarrierNLowsonKBarrowcloughC.Some aspects of family interventions in schizophrenia. II. Financial considerations. British Journal of Psychiatry1991; 159:481–484.
42.
HeldT.Schizophreniebehandlung in der Familie. Eine kontrollierte Studie zur Wirsamkeitfamilirer Verhaltenstherapie bei der Rückfallprophylaxe schizophrener EN krankungen. Frankfurt: Peter Lang, 1995.
43.
BrookerCFalloonIButterworthAGoldbergDGraham-HoleVHillierV.The outcome of training community psychiatric nurses to deliver psychosocial intervention. British Journal of Psychiatry1994; 165:222–230.
44.
FalloonIRHKyddRRCoverdaleJLaidlawTMEarly detection and intervention for initial episodes of schizophrenia. Schizophrenia Bulletin1996; 22:271–282.
